AMRX News and Press, Amneal Pharmaceuticals Inc. Class A From 08/23/21

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) today announced that it will host a virtual event for the investment community on Wednesday, August 25, 2021 at 4:30 p.m. ET. The upcoming event will feature members of Amneal’s management team as well as Alberto Espay, MD, MSc, FAAN, FAN...

Image source: The Motley Fool. Amneal Pharmaceuticals, inc (NYSE: AMRX) Q2 2021 Earnings Call Aug 9, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: Amneal Pharmaceuticals, inc (AMRX) Q2 2021 Earnings Call Transcrip...

Amneal Pharmaceuticals, Inc. (AMRX) Q2 2021 Earnings Conference Call August 09, 2021 08:00 AM ET Company Participants Tony DiMeo - Head of Investor Relations Chirag Patel - Co-Chief Executive Officer Chintu Patel - Co-Chief Executive Officer Tasos Konidaris - Chief Financial Officer Andy Boye...

The following slide deck was published by Amneal Pharmaceuticals, Inc. in conjunction with their 2021 Q2 earnings call. For further details see: Amneal Pharmaceuticals, Inc. 2021 Q2 - Results - Earnings Call Presentation

‒ Q2 2021 Net Revenue of $535 million; GAAP Net Income of $15 million; Diluted Income per Share of $0.10 ‒ ‒ Adjusted EBITDA (1) of $151 million; Adjusted Diluted EPS (1) of $0.25 ‒ ‒ Maintaining 2021 Full Year Financial Outlo...

AMRX,APD,AVYA,BALY,BHVN,BLUE,BNTX,CEVA,CRNC,DISH,EBIX,ELAN,ENR,EPZM,GOLD,GTES,KOD,RDNT,SGMS,SWAV,SYNH,TGNA,TSN,TTD,USFD,VTRS,VTR For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings before Monday's open

Pgiam/iStock via Getty Images Earnings reports dominated the headlines on Tuesday. IBM (IBM) and HCA Healthcare (HCA) both gained ground in pre-market action following their quarterly releases. PPG Industries (PPG) dropped following the announcement of its financial figures. There were also s...

RealPeopleGroup/E+ via Getty Images The FDA has approved an ANDA from Amneal Pharmaceuticals ([[AMRX]] +0.2%) for a generic of TobraDex (dexamethasone and tobramycin ophthalmic suspension).The drug is indicated for for steroid-responsive inflammatory ocular conditions.Sales of TobraDex f...

- Adding another complex ophthalmic product to the generics portfolio Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced that it has received Abbreviated New Drug Application (ANDA) approval from the U.S. Food an...

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that the Company will release its second quarter 2021 financial results on Monday, August 9, 2021, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:00 a.m. Eastern ...